| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2000;31:582.)
© 2000 American Heart Association, Inc.
Original Contributions |
Management Patterns and Costs of Acute Ischemic Stroke
An International Study
From Caro Research (J.J.C., K.F.H.), Concord, Mass; the Division of General Internal Medicine (J.J.C.), Royal Victoria Hospital, McGill University, Montreal, Canada; and the Janssen Research Foundation (I.D.), Beerse, Belgium.
Correspondence to J. Jaime Caro, Caro Research, 336 Baker Ave, Concord, MA 01742. E-mail jcaro{at}caroresearch.com
Background and Purpose—With the ever-increasing pressure on healthcare budgets, we witness a growing demand for evidence of the economic implications of care across many therapeutic areas. Stroke is no exception.
Methods—Detailed information on healthcare use was collected in conjunction with two 12-week international trials designed primarily to assess the safety and efficacy of a new potential neuroprotective agent. The information was gathered prospectively by means of a customized resource use instrument that included both acute and long-term inpatient management as well as community care. In this report, the results pertaining to the 1341 acute ischemic stroke patients are described.
Results—More than 70% of the mean cost ($13 668) was explained by the initial hospitalization, which averaged 24 days. The total cost and its components varied according to patient age, the presence of comorbidities, and several indicators of disease severity. Pronounced country differences could be observed in the management of this fairly homogeneous patient group.
Conclusions—This study provides a comprehensive picture of the healthcare services used for the treatment and rehabilitation of stroke victims, presented with respect to various patient and disease characteristics. It is expected that researchers evaluating the cost-efficiency of specific stroke treatments will benefit from the detailed information presented in this report.
Key Words: clinical trials • costs and cost analysis • stroke management
This article has been cited by other articles:
 |
|
 |
|
  E. A. Nutescu ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2281 - 2291. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Wagner, C. E Lang, S. A Sahrmann, D. F Edwards, and A. W Dromerick Sensorimotor Impairments and Reaching Performance in Subjects With Poststroke Hemiparesis During the First Few Months of Recovery Physical Therapy, June 1, 2007; 87(6): 751 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Kolominsky-Rabas, P. U. Heuschmann, D. Marschall, M. Emmert, N. Baltzer, B. Neundorfer, O. Schoffski, K. J. Krobot, and for the CompetenceNet Stroke Lifetime Cost of Ischemic Stroke in Germany: Results and National Projections From a Population-Based Stroke Registry: The Erlangen Stroke Project Stroke, May 1, 2006; 37(5): 1179 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saposnik, F. Webster, C. O'Callaghan, and V. Hachinski Optimizing Discharge Planning: Clinical Predictors of Longer Stay After Recombinant Tissue Plasminogen Activator for Acute Stroke Stroke, January 1, 2005; 36(1): 147 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Sacchetti Stroke Is Best Managed by Neurologists Stroke, June 1, 2004; 35(6): e149 - e150. [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Chang and M.-C. Tseng Costs of Acute Care of First-Ever Ischemic Stroke in Taiwan Stroke, November 1, 2003; 34 (11): e219 - e221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Aslanyan, C. J. Weir, K. R. Lees, J. L. Reid, and G. T. McInnes Effect of Area-Based Deprivation on the Severity, Subtype, and Outcome of Ischemic Stroke Stroke, November 1, 2003; 34(11): 2623 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fox Poststroke patients: implications for the cardiologist Eur. Heart J. Suppl., July 1, 2003; 5(suppl_E): E4 - E10. [Abstract] [PDF]
|
|
|
|
|
|
Y. Yoneda, T. Uehara, H. Yamasaki, Y. Kita, M. Tabuchi, and E. Mori Hospital-Based Study of the Care and Cost of Acute Ischemic Stroke in Japan Stroke, March 1, 2003; 34(3): 718 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Teng, N. E. Mayo, E. Latimer, J. Hanley, S. Wood-Dauphinee, R. Cote, and S. Scott Costs and Caregiver Consequences of Early Supported Discharge for Stroke Patients Stroke, February 1, 2003; 34(2): 528 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Reed, D. K. Blough, K. Meyer, and J. G. Jarvik Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals Neurology, July 24, 2001; 57(2): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jakovljevic, C. Sarti, J. Sivenius, J. Torppa, M. Mahonen, P. Immonen-Raiha, E. Kaarsalo, K. Alhainen, K. Kuulasmaa, J. Tuomilehto, et al. Socioeconomic Status and Ischemic Stroke : The FINMONICA Stroke Register Stroke, July 1, 2001; 32(7): 1492 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. U. Weir, P. A. G. Sandercock, S. C. Lewis, D. F. Signorini, and C. P. Warlow Variations Between Countries in Outcome After Stroke in the International Stroke Trial (IST) Stroke, June 1, 2001; 32(6): 1370 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Handschu, A. Garling, P. U. Heuschmann, P. L. Kolominsky-Rabas, F. Erbguth, and B. Neundorfer Acute Stroke Management in the Local General Hospital Stroke, April 1, 2001; 32(4): 866 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Caro, K. F. Huybrechts, and H. E. Kelley Predicting Treatment Costs After Acute Ischemic Stroke on the Basis of Patient Characteristics at Presentation and Early Dysfunction Stroke, January 1, 2001; 32(1): 100 - 106. [Abstract] [Full Text] [PDF]
|
|